Literature DB >> 6157063

Aprotinin and insulin resistance.

J C Pickup, R W Bilous, H Keen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6157063     DOI： 10.1016/s0140-6736(80)92976-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Subcutaneous degradation of insulin.

Authors:  R W Stevenson
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

2.  Evidence for insulin degradation by muscle and fat tissue in an insulin resistant diabetic patient.

Authors:  G F Maberly; G A Wait; J A Kilpatrick; E G Loten; K R Gain; R D Stewart; C J Eastman
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

3.  Subcutaneous aprotinin causes local hyperaemia. A possible mechanism by which aprotinin improves control in some diabetic patients.

Authors:  G Williams; J C Pickup; S Bowcock; E Cooke; H Keen
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

4.  Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.

Authors:  J C Pickup; P D Home; R W Bilous; H Keen; K G Alberti
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

5.  Implantable infusion pump management of insulin resistant diabetes mellitus.

Authors:  H Buchwald; E P Chute; F J Goldenberg; C R Hitchcock; B J Hoogwerf; J J Barbosa; W M Rupp; T D Rohde
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.